June 2024

The company behind the Esquires Coffee chain has seen its sales jump by more than 30 per cent in the UK as a raft of new store openings begins to…

Astrazeneca’s Imfinzi drug has been approved in the US for use on patients with primary or advanced endometrial cancer. The Food and Drug Administration (FDA) has issued approval for the…

Emmanuel Macron’s election gamble has caused France to lose its crown as Europe’s biggest stock market, with London overtaking it to retake the title after spending most of the last…

Mindgym swung to a loss in 2024 as macroeconomic headwinds impacted confidence in key sectors. Adjusted earnings before interest, taxation, depreciation and amortization (EBITDA) fell over 106 per cent from…

Specialist lender Shawbrook has struck a deal to acquire motor finance lender JBR Auto Holdings as it looks to expand its car loan offering. The group announced on Monday that…

Andy Murray may be on his lap of honour but, as the grass-court season cranks up a notch at Queen’s Club this week, the Lawn Tennis Association is feeling bullish…

A former-Tesco exec is set to join the leadership team at Kingfisher, which owns B&Q and Screwfix, following the resignation of its chief financial officer Bernard Bot. Bhavesh Mistry, who…

The founders of the investment group Melrose Industries are plotting to list a new investment vehicle on London’s AIM market. Veteran dealmaker Simon Peckham is reportedly leading the launch of…

Property fintech Lendinvest has issued a profit warning for its 2024 financial year after an accounting error related to a £5m securitisation deal. The firm, which operates an online marketplace…

Hikma Pharmaceuticals has bolstered its US injectables capabilities by purchasing several divisions of Danish competitor Xellia Pharmaceuticals. The company said it would pay a $135m (£106m) cash consideration upfront and…